Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment the losartan intervention for end-point reduction in hypertension study (LIFE)

Circulation

Volumn 119, Issue 14, 2009, Pages 1883-1891

  Okin, Peter M ^a   Oikarinen, Lasse ^b   Viitasalo, Matti ^b   Toivonen, Lauri ^b   Kjeldsen, Sverre E ^c,d   Nieminen, Markku S ^b   Edelman, Jonathan M ^e   Dahlöf, Björn ^f   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Electrocardiography; Epidemiology; Hypertension; Hypertrophy; Mortality

Indexed keywords

ATENOLOL; LOSARTAN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STROKE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; ANAMNESIS; CARDIOVASCULAR DISEASE; DIASTOLE; HYPERTENSION; MECHANICAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; SYSTOLE;

AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CARDIOVASCULAR DISEASES; DIASTOLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STRESS, MECHANICAL; SYSTOLE;

EID: 65549108380     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.812313     Document Type: Article

References (29)

1. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
2. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-759.
3. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391-1398.
4. Devereux RB, Reichek N. Repolarization abnormalities of left ventricular hypertrophy: clinical, echocardiographic and hemodynamic correlates. J Electrocardiol. 1982;15:47-53.
5. Levy D, Labib SB, Andersen KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815-820.
6. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, Battistelli M, Bartoccini C, Porecellata C. Improved electrocardiographic diagnosis of echocardiographic left ventricular hypertrophy. Am J Cardiol. 1994;74:714-719.
7. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlof B. Relationship of the electro- cardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE Study. J Am Coll Cardiol. 2001;38:514-520.
8. Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV. Quantitative assessment of electrocardiographic left ventricular strain predicts increased left ventricular mass: the Strong Heart Study. J Am Coll Cardiol. 2002;40:1395-1400.
9. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation. 1961;33:697-713.
10. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 1998;31: 383-390.
11. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlof B. Electro- cardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension. 2004;44: 48 -54.
12. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1970;72:813-822.
13. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786 -1793.
14. Verdecchia P, Reboldi G, Angeli F, Avanzini F, de Simone G, Pede S, Perticone F, Schillaci G, Vanuzzo D, Maggioni AP; on behalf of the HEART Survey Study Group. Prognostic value of serial electrocardio- graphic voltage and repolarization changes in essential hypertension: the HEART Survey Study. Am J Hypertens. 2007;20:997-1004.
15. Prineas RJ, Rautaharju PM, Grandits G, Crow R; MRFIT Research Group. Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the Multiple Risk Factor Intervention Trial. J Electrocardiol. 2001;34:91-101.
16. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf; Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the an- giotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104: 1615-1621.
17. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Leonetti G, Sarti C, Tuomilehto J, Webster J, Yodfat Y; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension. 2004;44: 459 -464.
18. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events: the LIFE Study. JAMA. 2004;292:2343-2349.
19. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359: 995-1003.
20. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; for the LIFE Study Group. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens. 1997;10: 705-713.
21. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-423.
22. Palmieri V, Bella J, DeQuattro V, Roman MJ, Hahn RT, Dahlof B, Sharpe N, Lau C-P, Chen W-C, Paran E, de Simone G, Devereux RB. Relation of left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (the PRESERVE study). Am J Cardiol. 1999;94:558-562.
23. Wachtell K, Okin PM, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K. Regression of electrocardio- graphic left ventricular hypertrophy during antihypertensive therapy and reduction of cardiac death: the LIFE Study. Circulation. 2007;116: 700-705.
24. Sales G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Hypertension. 2006;48:437-442.
25. Rembert JC, Kleinman LH, Fedor JM, Wechsler AS, Greenfield JC Jr. Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest. 1978;62:379-386.
26. O'Keefe JH, Owen RM, Bove AA. Influence of left ventricular mass on coronary artery cross-sectional area. Am J Cardiol. 1987;59:1395-1397.
27. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary flow velocity in related to lumen area and regional left ventricular mass. Circulation. 2000;102:48 -54.
28. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317:787-792.
29. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension. 2004;43: 769-774.